SCHEMBL9300899

SCHEMBL9300899

C=CC[CH]CC(=C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3046721 0.78
SCHEMBL3186465 0.76 TSHR (0.34)
SCHEMBL135896 0.76
Lithium SCHEMBL31299674 0.73
SCHEMBL6190992 0.71
SCHEMBL11784166 0.70
SCHEMBL11784163 0.70
SCHEMBL11351625 0.69 TSHR (0.41)
SCHEMBL148792 0.67
SCHEMBL5611405 0.67 ALDH1A1 (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5354768-A Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents SANKYO COMPANY, LIMITED (JP) 1994-10-11 US disclosed
US-5190934-A Treatment of cognitive and memory disorders CIBA-GEIGY CORPORATION (US) 1993-03-02 US disclosed